ALinC 17: Protocol for Patients With Newly Diagnosed High Risk Acute Lymphoblastic Leukemia (ALL) - Evaluation of the Augmented BFM Regimen: A Phase III Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Mercaptopurine; Methotrexate; Prednisone; Tioguanine; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 20 Feb 2014 Biomarkers information updated
- 05 Oct 2009 Additional lead investigators added as reported by New Jersey Cancer Trial Connect record.
- 05 Oct 2009 New source identified and integrated (New Jersey Cancer Trial Connect; COG-P9906)